• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Isorhapontigenin protects against doxorubicin-induced cardiotoxicity <i>via</i> increasing YAP1 expression.

广告
作者: Panxia,Wang [1] ; Minghui,Wang [1] ; Yuehuai,Hu [1] ; Jianxing,Chen [1] ; Yanjun,Cao [1] ; Cui,Liu [1] ; Zhongkai,Wu [2] ; Juan,Shen [3] ; Jing,Lu [1] ; Peiqing,Liu [1]
作者单位: School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China. [1] Department of Cardiac Surgery, First Affiliated Hospital, Sun Yat-sen University, Guangzhou 510080, China. [2] Guangdong Provincial Key Laboratory of Pharmaceutical Bioactive Substances, Guangdong Pharmaceutical University, Guangzhou 510006, China. [3] Guangdong Provincial Key Laboratory of New Drug Design and Evaluation, Sun Yat-sen University, Guangzhou 510006, China. [4] Guangdong Provincial Engineering Laboratory of Druggability and New Drugs Evaluation, Guangzhou 510006, China. [5]
关键词 AMPK, AMP-activated protein kinaseAP-1, anti-microbial proteinAREG, amphiregulinAUC/Dose, dose-normalized plasma exposuresAmphiregulinAng II, angiotensin IICO, cardiac outputCTGF, connective tissue growth factorCardiomyocytes apoptosisCardiotoxicityCmax/Dose, dose-normalized maximal plasma concentrationsConnective tissue growth factorDAB, 3,3′-diaminobenzidineDMEM, Dulbecco's modified Eagle's mediumDob, dobutamineDox, doxorubicinDoxorubicinEMT, epithelial mesenchymal transformationFOXO1, forkhead box class O1FS, fractional shorteningHE, hematoxylin–eosinISO, isoproterenolIsor, isorhapontigeninIsorhapontigeninLVAW;d, left ventricular end-diastolic anterior wall thicknessLVAW;s, left ventricular end-systolic anterior wall thicknessLVEF, left ventricular ejection fractionLVID;d, left ventricular end-diastolic internal diameterLVID;s, left ventricular end-systolic internal diameterLVPW;d, left ventricular end-diastolic posterior wall thicknessLVPW;s, left ventricular end-systolic posterior wall thicknessMAPK, mitogen-activated protein kinaseMI, myocardial infarctionNF-κB, nuclear factor kappa-BNRCMs, neonatal rat cardiomyocytesP2Y12 receptor, ADP receptorPGC-1α, peroxisome proliferator-activated receptor γ coactivator-1αPMSF, phenylmethanesulfonyl fluoridePVDF, polyvinylidene fluorideROS, reactive oxygen speciesSD, Sprague–DawleySDS-PAGE, sodium dodecyl sulfate-polyacrylamide gel electrophoresisSESN2, sestrin2TCF4, T-cell factor 4TEAD, TEA domain transcription factor proteinsTEAD1TUNEL, TdT-mediated dUTP nick end labelingWGA, wheat germ agglutininYAP1YAP1, Yes-associated protein 1qRT-PCR, quantitative real-time polymerase chain reactionsgRNAs, sequence guiding RNAsΔψm, mitochondrial membrane potential
DOI 10.1016/j.apsb.2020.10.017
PMID 33777675
发布时间 2021-03-30
提交
  • 浏览2
Acta pharmaceutica Sinica. B

Acta pharmaceutica Sinica. B

2021年11卷3期

680-693页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷